HOME >> MEDICINE >> NEWS
Nutrition studies' conclusions tied to funding source

Recent analyses have documented bias in pharmaceutical studies funded by industry. Now, an analysis from Children's Hospital Boston finds a similar phenomenon in scientific articles about nutrition, particularly in studies of beverages. The analysis the first systematic one performed on nutrition studies found that beverage studies funded solely by industry were four to eight times more likely to have conclusions favorable to sponsors' financial interest than were studies with no industry funding. Findings are published online in the January 9 issue of the journal PLoS Medicine.

David Ludwig, MD, PhD, the study's senior author and director of the Optimal Weight for Life (OWL) program at Children's Hospital Boston, believes that bias in nutrition studies may have far greater effects than bias in pharmaceutical studies. Not only do the findings of nutrition studies receive frequent media attention, but they influence governmental and professional dietary guidelines, the design of intervention programs, and FDA regulation of health claims on foods and beverages.

"We don't all take drugs, but we eat every day," Ludwig says. "If the science base is compromised by conflict of interest, that's a top-order threat to public health."

Because the researchers focused their analysis on soft drinks, juice and milk, they aren't sure whether their findings extend to nutrition studies as a whole. "We chose beverages because they represent an area of nutrition that's very controversial, that's relevant to children, and involves a part of the food industry that is highly profitable and where research findings could have direct financial implications," Ludwig says.

The researchers began by conducting a Medline search of all existing scientific literature about soft drinks, juice and milk published during a five-year period (1999-2003). They retrieved 538 articles, of which 206 were eligible for analysis. Eligible articles had to look at heal
'"/>

Contact: Andrea Duggan
andrea.duggan@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
8-Jan-2007


Page: 1 2 3

Related medicine news :

1. Nutrition specialist says approach to treating severe malnutrition still fails millions of children
2. Nutritional interventions for the aging in developing countries to reduce disease burden?
3. Nutrition expert evaluates new weight-loss medication
4. Nutritional info helps teens make better choices
5. Nutrition gene key in regulating immune system
6. Nutritional advice improves health of children in developing countries
7. Nutritional supplement reduces need for traditional ulcerative colitis treatment
8. SCHIP funding levels too low ACP tells Senate Finance Committee Leaders
9. Physician-researchers often less successful in obtaining NIH funding
10. NIH funding UIC brain tumor research
11. Research ethics committees in Africa report inadequate funding, staffing and training

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nutrition studies conclusions tied funding source

(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: